INTENSIVE REVIEW of NEPHROLOGY 2024 TOPICS
1. Renal Physiology for the Boards – Melanie P. Hoenig, MD
2. Basic Concepts of Immunology in Autoimmune Kidney Disease – Ramon G. Bonegio, MD
3. Question and Answer Session – Faculty
4. Renal Pathology in 2023 – Part 1 – Nephritic Conditions – Helmut G. Rennke, MD
5. Renal Pathology in 2023 – Part 2 – Nephritic Syndrome – Astrid Weins, MD, PhD
6. Current Approaches to Urine Sediment Analysis – Martina M. McGrath, MB BCh
7. Question and Answer Session – Faculty
8. Pathogenesis, Diagnosis, and Treatment of IgA Nephropathy – Gerald B. Appel, MD
9. Metabolic Management of Kidney Stones – Gary C. Curhan, MD, ScD
10. Social Determinants – Disparities in Renal Disease – Winfred W. Williams, Jr., MD
11. Question and Answer Session – Faculty
12. Update on Lupus Nephritis – Gerald B. Appel, MD
13. Membranous Nephropathy – Laurence H. Beck, Jr., MD, PhD
14. Anemia Management – Update and Best Practices – Ajay K. Singh, MBBS, FRCP (UK), MBA
15. Question and Answer Session – Faculty
16. Acid-Base Disorders Part I – Anion Gap Metabolic Acidosis – Alan S.L. Yu, MB, BChir
17. Acid-Base Disorders II – Non-Gap Acidosis and Metabolic Alkalosis – Alan S.L. Yu, MB, BChir
18. Question and Answer Session – Faculty
19. Hyponatremia and Hypernatremia – David B. Mount, MD
20. Hypokalemia and Hyperkalemia – David B. Mount, MD
21. Question and Answer Session – Faculty
22. Important New Trials in Glomerular Disease – Saif Abdulkarim Muhsin, MB BCh
23. Genetics and Kidney Disease – Friedhelm Hildebrandt, MD
24. Update on Polycystic Kidney Disease – Cristian Riella, MD
25. Pediatric Nephrology – Michael J.G. Somers, MD
26. Genetics – How to Integrate It into Practice – Ana Onuchic-Whitford, MD
27. Rapidly Progressive Glomerulonephritis – John L. Niles, MD
28. Question and Answer Session – Faculty
29. Why Do We Reject a Transplant? – Jamil R. Azzi, MD
30. Transplant Immunosuppression for the Boards – Steven Gabardi, PharmD, BCPS, FAST, FCCP
31. Question and Answer Session – Faculty
32. Immunological Assessment Pre- and Post-Transplant – Melissa Y. Yeung, MD and Indira Guleria, PhD
33. Early Post-Transplant Management – Anil K. Chandraker, MD
34. Question and Answer Session – Faculty
35. Donor Evaluation – Kassem Safa, MD
36. Late Loss of the Kidney Transplant – John Y. Choi, MD
37. Infections in Transplant Recipients – Sarah P. Hammond, MD
38. Monitoring Kidney Transplant Patients – Beyond Creatinine – Jamil R. Azzi, MD
39. Pre-Transplant Surgical Evaluation of Recipients – Saif Abdulkarim Muhsin, MB BCh
40. Question and Answer Session – Faculty
41. Poisonings and Intoxications – What a Nephrologist Needs to Know – Timothy B. Erickson, MD
42. Late Post-Transplant Medical Complications – Leonardo V. Riella, MD, PhD
43. Hemolytic Uremic Syndrome (HUS) and Thrombotic Thrombocytopenic Purpura (TTP) – Jean M. Francis, MD
44. Geriatric Nephrology – Ernest I. Mandel, MD
45. Pathophysiology and Treatment of Diabetic Kidney Disease – Gearoid M. McMahon, MB BCh
46. Management of Hypertension in CKD-Intensive or Standard Regimens – Richard J. Glassock, MD
47. Question and Answer Session – Faculty
48. Primary Aldosteronism – Anand Vaidya, MD, MMSc
49. Xenotransplantation – The ImPossible Solution – Jayme E. Locke, MD, MPH, FACS, FAST
50. Liver and the Kidney – Andrew S. Allegretti, MD, MSc
51. Pathophysiology of Acute Kidney Injury – Joseph V. Bonventre, MD, PhD
52. Acute Kidney Injury Syndromes – Alice M. Sheridan, MD
53. ICU Nephrology and Continuous Renal Replacement Therapies – David J.R. Steele, MB BCh
54. Question and Answer Session – Faculty
55. Acute Kidney Injury in Cancer – Raad B. Chowdhury, MD, FASN
56. Dysproteinemia and Kidney Disease – The Clone Wars – Raad B. Chowdhury, MD, FASN
57. Therapy of Focal and Segmental Glomerulosclerosis (FSGS) Lesions in 2023 – Richard J. Glassock, MD
58. Cardio-Renal Syndrome – Finnian R. McCausland, MB BCh, MMSc, FRCPI
59. APOL1 and Kidney Disease – Opeyemi Olabisi, MD, PhD
60. Question and Answer Session – Faculty
61. Patient Perspective – Dialysis Dosing – Moderators: J. Kevin Tucker, MD and Paul Moore, RN, Dialysis Patients: Daphne Bryant and Vanessa Evans
62. Chronic Kidney Disease – Mineral and Bone Disease – David Bushinsky, MD
63. Question and Answer Session – Faculty
64. Dialysis – A Case-Based Clinical Review and Update – J. Kevin Tucker, MD
65. Pearls in Mineral and Bone Disease – David Bushinsky, MD
66. Chronic Kidney Disease Epidemiology – Gearoid M. McMahon, MB BCh
67. Question and Answer Session – Faculty
68. Introduction to Peritoneal Dialysis – Joanne M. Bargman, MD, FRCPC
69. Complications of Peritoneal Dialysis – Joanne M. Bargman, MD, FRCPC
70. Acute Kidney Injury Related to Immune Checkpoint Inhibitors – Shruti Gupta, MD, MPH
71. Mesoamerican Nephropathy – Ricardo Correa-Rotter, MD
72. Renal Ultrasound for the Clinical Nephrologist – Adina S. Voiculescu, MD
73. Dialysis Vascular Access – Assessment and Complications – Dirk M. Hentschel, MD
74. Glomerulonephritis – Questions & Answers Session – Gerald B. Appel, MD
75. Must-Know Clinical Images in Nephrology – Ajay K. Singh, MBBS, FRCP (UK), MBA
76. Electrolytes and Acid-Base Practice for the Boards – Part 1 – Alan S.L. Yu, MB, BChir
77. Electrolytes and Acid-Base Practice for the Boards – Part 2 – Alan S.L. Yu, MB, BChir
78. Chronic Kidney Disease in the Community – Leveraging Resources Effectively, Lessons Learned from KDSAP – Li-Li Hsiao, MD, PhD, FACP
79. COVID-19 Vaccination Response in Transplant Patients – Ann E. Woolley, MD
80. Update on Renovascular Disease – Joseph M. Garasic, MD
81. Pre-Transplant Surgical Evaluation of Recipients – Sayeed Malek, MD, FACS
82. Immunologic Basis of Kidney Disease – Vivek Kasinath, MD
83. Use of Checkpoint Inhibitors in Kidney Transplant Recipients – Naoka Murakami, MD, PhD
84. Interstitial Nephritis – Overview for the Boards – Julie M. Paik, MD, ScD, MPH
85. Ethics in Nephrology – Valerie Luyckx, MD, MB BCh
86. Pregnancy and Renal Disease – Jessica Tangren, MD
87. Transplant Cases: Board Review Practice – Melissa Y. Yeung, MD and Edgar L. Milford, Jr., MD
88. Transplant Board Review – Anil K. Chandraker, MD
89. Must-Know Board Zebras – Emily S. Robinson, MD, MPH
90. Nephrology Board Review Practice 1 – Finnian R. McCausland, MB BCh, MMSc, FRCPI
91. Nephrology Board Review Practice 2 – Mallika Mendu, MD, MBA